Cargando…
Gene editing innovations and their applications in cardiomyopathy research
Cardiomyopathies are among the major triggers of heart failure, but their clinical and genetic complexity have hampered our understanding of these disorders and delayed the development of effective treatments. Alongside the recent identification of multiple cardiomyopathy-associated genetic variants...
Autores principales: | Kyriakopoulou, Eirini, Monnikhof, Thomas, van Rooij, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233723/ https://www.ncbi.nlm.nih.gov/pubmed/37222281 http://dx.doi.org/10.1242/dmm.050088 |
Ejemplares similares
-
Fibro-fatty remodelling in arrhythmogenic cardiomyopathy
por: Kohela, Arwa, et al.
Publicado: (2022) -
Innovative Precision Gene‐Editing Tools in Personalized Cancer Medicine
por: Dai, Xiaofeng, et al.
Publicado: (2020) -
Gene Editing Regulation and Innovation Economics
por: Whelan, Agustina I., et al.
Publicado: (2020) -
Genome Editing for the Understanding and Treatment of Inherited Cardiomyopathies
por: Nguyen, Quynh, et al.
Publicado: (2020) -
Review of applications of CRISPR-Cas9 gene-editing technology in cancer research
por: Zhao, Ziyi, et al.
Publicado: (2021)